Zacks Investment Research upgraded shares of PROTALIX BIOTHR (PLX) from NEUTRAL to OUTPERFORM on June 19, 2013, with a target price of $5.60.
ORTHODONTIX INC. is engaged in the provision of practice management services to the Affiliated Practices pursuant to long-term Administrative Services Agreements with separately organized affiliated professional associations. Under the Administrative Services Agreements, they have control over all non-orthodontic functions of the PA Contractors, including administrative, management, billing and support functions.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on PROTALIX BIOTHR (PLX),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment